Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selarivavir potassium + sofosbuvir in genotype 1 chronic hepatitis C (non-cirrhotic) adults
CTR20182134Phase 3Completed
- Sponsor
- Ginkgo Tree Pharmaceutical
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of selarivavir potassium, sofosbuvir in chronic hepatitis C (CHC), sponsored by Ginkgo Tree Pharmaceutical. Started Dec 2018; status: completed.
02
Drugs
selarivavir potassiumsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20182134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182134.